Vitamin D and prostate cancer prevention.

IF 2.6 Q3 ONCOLOGY

World journal of clinical oncology Pub Date : 2024-06-24 DOI:10.5306/wjco.v15.i6.691

Evita Krumina, Abrahams Ocanto, Felipe Couñago

引用次数: 0

Abstract

Vitamin D is a hot topic nowadays, especially its relationship with cancer prevention. Normally, vitamin D is associated with bone health principally, but the new research has discovered an impact on immune function and cellular signaling, even in same studies talk about a hormone, however, the most important relationship is its implication in cellular processes, inhibiting cancer growth. For now, the recent studies are oriented about a benefit and a cause-effect relationship between prostate cancer and normal levels of vitamin D. This premise opens a lot of questions in this scenario. This editorial highlighted the most important studies in this area.

查看原文本刊更多论文

维生素 D 和前列腺癌的预防。

维生素 D 是时下的热门话题，尤其是它与癌症预防的关系。通常情况下，维生素 D 主要与骨骼健康有关，但新的研究发现它对免疫功能和细胞信号传导也有影响，甚至在同样的研究中也谈到了激素，然而，最重要的关系是它对细胞过程的影响，即抑制癌症生长。就目前而言，最新研究的方向是前列腺癌与正常水平维生素 D 之间的益处和因果关系。这篇社论强调了这一领域最重要的研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

World journal of clinical oncology ONCOLOGY-

自引率

0.00%

发文量

585

期刊介绍： The WJCO is a high-quality, peer reviewed, open-access journal. The primary task of WJCO is to rapidly publish high-quality original articles, reviews, editorials, and case reports in the field of oncology. In order to promote productive academic communication, the peer review process for the WJCO is transparent; to this end, all published manuscripts are accompanied by the anonymized reviewers’ comments as well as the authors’ responses. The primary aims of the WJCO are to improve diagnostic, therapeutic and preventive modalities and the skills of clinicians and to guide clinical practice in oncology. Scope: Art of Oncology, Biology of Neoplasia, Breast Cancer, Cancer Prevention and Control, Cancer-Related Complications, Diagnosis in Oncology, Gastrointestinal Cancer, Genetic Testing For Cancer, Gynecologic Cancer, Head and Neck Cancer, Hematologic Malignancy, Lung Cancer, Melanoma, Molecular Oncology, Neurooncology, Palliative and Supportive Care, Pediatric Oncology, Surgical Oncology, Translational Oncology, and Urologic Oncology.